{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:14Z","timestamp":1762505354798},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jns.2008.02.017","type":"journal-article","created":{"date-parts":[[2008,4,19]],"date-time":"2008-04-19T13:07:35Z","timestamp":1208610455000},"page":"122-126","source":"Crossref","is-referenced-by-count":16,"title":["Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms"],"prefix":"10.1016","volume":"270","author":[{"given":"Joong-Seok","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Uk","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong-In","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ryung","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.02.017_bib1","first-page":"349","article-title":"Radiochemistry and radiopharmaceurticals: radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with I-131 iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jns.2008.02.017_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","article-title":"Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease","volume":"76","author":"Nagayama","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.02.017_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.parkreldis.2005.12.008","article-title":"Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?","volume":"12","author":"Matsui","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2008.02.017_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0404.1998.tb05958.x","article-title":"Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure","volume":"97","author":"Braune","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2008.02.017_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","article-title":"Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease","volume":"19","author":"Yoshita","year":"1998","journal-title":"Nucl Med Common"},{"key":"10.1016\/j.jns.2008.02.017_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2005.11.034","article-title":"Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease","volume":"243","author":"Mitsui","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.02.017_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","article-title":"Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease","volume":"17","author":"Orimo","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2008.02.017_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.74.4.423","article-title":"Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease","volume":"74","author":"Hamada","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.02.017_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2004.02.018","article-title":"Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD","volume":"220","author":"Saiki","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.02.017_bib10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.21499","article-title":"Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease","volume":"22","author":"Spiegel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2008.02.017_bib11","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","article-title":"Criteria for diagnosing Parkinson's disease","volume":"32","author":"Calne","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.02.017_bib12","first-page":"245","article-title":"Research diagnostic criteria for Parkinson's disease","volume":"53","author":"Ward","year":"1990","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jns.2008.02.017_bib13","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/mds.10579","article-title":"Correlation of dopamine transporter imaging with Parkinsonian motor handicap: how close is it?","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2008.02.017_bib14","first-page":"S29","article-title":"Various aspects of motor fluctuations and their management in Parkinson's disease","volume":"44","author":"Mizuno","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.02.017_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.02.017_bib16","first-page":"283","article-title":"Catecholamine-related enzymes in the brain of patients with parkinsonism and Wilson's disease","volume":"24","author":"Nagatsu","year":"1979","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jns.2008.02.017_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2220\/biomedres.3.95","article-title":"Dopamine beta hydroxylase activity in cerebrospinal \ufb02uid of parkinsonian patients","volume":"3","author":"Nagatsu","year":"1982","journal-title":"Biomed Res"},{"key":"10.1016\/j.jns.2008.02.017_bib18","first-page":"525","article-title":"L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease","volume":"16","author":"Ogawa","year":"1985","journal-title":"J Med"},{"key":"10.1016\/j.jns.2008.02.017_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02260912","article-title":"The effects of l-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients","volume":"5","author":"Tohgi","year":"1993","journal-title":"J Neural Transm, Parkinson's Dis Dement Sect"},{"key":"10.1016\/j.jns.2008.02.017_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00006231-200303000-00006","article-title":"Cardiac innervation and clinical correlates in idiopathic Parkinson's disease","volume":"24","author":"Akincioglu","year":"2003","journal-title":"Nucl Med Common"},{"key":"10.1016\/j.jns.2008.02.017_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jns.2006.05.026","article-title":"Vascular parkinsonism \u2014 an update","volume":"248","author":"Rektor","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.02.017_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","article-title":"Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease","volume":"18","author":"Taki","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jns.2008.02.017_bib23","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mds.20996","article-title":"Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: autonomic symptom and demographic comparison","volume":"21","author":"Allcock","year":"2006","journal-title":"Mov Disord"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T14:36:11Z","timestamp":1557498971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0022510X08000981"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.02.017","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}